Novozymes Other Non-Current Liabilities 2011-2023 | NVZMY

Novozymes other non-current liabilities for the quarter ending December 31, 2023 were $0.037B, a 76.57% decline year-over-year.

  • Novozymes other non-current liabilities for 2023 were $0.037B, a 76.57% decline from 2022.
  • Novozymes other non-current liabilities for 2022 were $0.156B, a 30.53% decline from 2021.
  • Novozymes other non-current liabilities for 2021 were $0.225B, a 58.25% decline from 2020.

Novozymes Other Non-Current Liabilities 2011-2023 | NVZMY

  • Novozymes other non-current liabilities for 2023 were $0.037B, a 76.57% decline from 2022.
  • Novozymes other non-current liabilities for 2022 were $0.156B, a 30.53% decline from 2021.
  • Novozymes other non-current liabilities for 2021 were $0.225B, a 58.25% decline from 2020.